Palliative Medicine

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heath, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Heath, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Palliative Medicine, Vol. 3, No. 1, 1-11 (1989)
DOI: 10.1177/026921638900300102
© 1989 SAGE Publications

Reviews

Review article : Hypercalcaemia of malignancy

DA Heath

Department of Medicine, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK

This article reviews the incidence and clinical features of hypercalcaemia caused by malignancy. The pathogenesis is examined, looking at recent evidence on endocrinological processes, particularly parathyroid hormone related protein. Finally the article reviews current thinking on treatment.

Key Words: diphosphonates • drug therapy • hypercalcaemia • neoplasms • palliative treatment • parenteral infusion


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?